Uihlein Richard E

CIK 00016949031 companyNORCROSS, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001694903

Recent Transactions

50 trades

Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-16$3.04/sh+13,158→ 10,332,676 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2026-01-16+60,000→ 60,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-01-23+60,000→ 60,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-01-23$1.23/sh+32,520→ 10,301,271 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-01-24$1.72/sh+23,256→ 10,268,751 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2024-01-24+50,000→ 50,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-09-26$5.00/sh+1,466,204→ 9,466,495 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-09-26$3.00/sh+200,000→ 9,835,495 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-09-26$3.00/sh+200,000→ 10,235,495 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2023-09-26−200,000→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-09-26$5.00/sh+170,000→ 9,635,495 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-09-26$3.26/sh+200,000→ 10,035,495 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2023-09-26−200,000→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2023-09-26−1,466,204→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2023-09-26−170,000→ 330,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2023-09-26−200,000→ 0 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2023-01-26$1.11/sh+36,036→ 7,999,291 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2023-01-26+40,000→ 40,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2022-01-24$1.98/sh+17,677→ 7,936,677 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2022-01-24+40,000→ 40,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Convertible Note
2021-12-20$10000000.00/sh+1,841,621→ 10,000,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Convertible Note
2021-09-17$10000000.00/sh+1,157,407→ 10,000,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Convertible Note
2021-04-16$10000000.00/sh+2,000,000→ 10,000,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2021-03-25+40,000→ 40,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2021-03-25+70,000→ 70,000 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2020-09-04$2.55/sh+10,000→ 7,893,191 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2020-02-13−18,638→ 21,362 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2020-02-13$2.39/sh+46,875→ 7,864,553 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2020-02-13$4.72/sh+18,638→ 7,883,191 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2020-02-13−46,875→ 0 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2020-01-09$2.86/sh+12,238→ 7,817,678 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2020-01-09+45,000→ 45,000 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-05-31$4.28/sh+7,710→ 27,710 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2019-05-31+15,576,322→ 15,576,322 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-05-31$4.28/sh+4,672,896→ 7,801,385 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2019-05-31+25,700→ 25,700 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2019-05-31+25,700→ 25,700 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-05-31$4.28/sh+4,672,896→ 7,801,385 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-05-31$4.28/sh+7,710→ 27,710 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2019-05-29−500,000→ 966,204 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-05-29$5.00/sh+500,000→ 3,128,489 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2019-05-29+15,576,322→ 15,576,322 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-05-29$5.00/sh+500,000→ 3,128,489 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock Purchase Warrant (right to buy)
2019-05-21−500,000→ 966,204 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-04-09$4.82/sh+20,700→ 2,628,489 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-04-05$4.81/sh+21,000→ 2,607,789 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-01-29$4.87/sh+48,500→ 2,586,789 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-01-29$4.87/sh+48,500→ 2,586,789 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-01-28$4.77/sh+3,000→ 2,538,289 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-01-28$4.77/sh+3,000→ 2,538,289 total

Companies

GALECTIN THERAPEUTICS INC
Director, 10% Owner
$GALT

Recent Filings

Address

4960 PEACHTREE INDUSTRIAL BLVD SUITE 240

NORCROSS, GA, 30071

View on SEC.gov